 |
|
|
|
|
| Nucleoside
/ Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trizivir (abacavir/lamivudine/
zidovudine)
|
|
•
|
|
|
•
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| non
Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Protease
Inhibitors (PIs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Fixed-dose
Combinations |
 |
 |
 |
 |
 |
Atripla
(efavirenz/emtricitabine/
tenofovir)
|
|
•
|
|
|
•
|
|
|
|
|
Trizivir (abacavir/lamivudine/
zidovudine)
|
|
•
|
|
|
•
|
|
|
|
| |
|
|
| Fusion
Inhibitor (FIs) |
|
CCR5
Antagonist |
|
Integrase
Inhibitor |
 |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
